Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 67, Issue 5, Pages 1025-1039Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2012.02.010
Keywords
adverse events; cancer treatment; Common Terminology Criteria for Adverse Events; drug reactions; grading system; side effects
Categories
Funding
- US National Institutes of Health
- Zell Scholarship from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Dermatology Foundation Career Development Award
Ask authors/readers for more resources
Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer. (J Am Acad Dermatol 2012;67:1025-39.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available